3 ms·
> You may have heard about monoclonal antibody therapies to covid ... those, unfortunately, are very susceptible to mutation because if a critical targeted resi
by Scoundreller 5y ago
> You may have heard about monoclonal antibody therapies to covid ... those, unfortunately, are very susceptible to mutation because if a critical targeted residue mutates, you could lose all efficacy of the drug.
Depends if the therapy works on the virus itself, or your body's response to the infection.
I think most of the monoclonal antibodies are working on your body's (over)response, so mutations shouldn't change much. Same with corticosteroids.
But Nucloside/tide analogues on the other hand or anything else working against viral processes/replication, oh yeah.
- hanklazard 5y agoI should have been more clear about the monoclonals I was referring to, which are those targeting the virus itself (1). You may be thinking of the targeted immune modulators against inflammatory cytokines like TNF-alpha (2) and IL-6 (3). Some of those are antibodies, others are pieces of antibody fused to other proteins. Regardless, those types of treatments would not be affected directly by viral mutation, whereas the first type I described above have already been shown to be less effective with existing mutations (4). 1. https://en.m.wikipedia.org/wiki/Casirivimab/imdevimab https://en.m.wikipedia.org/wiki/Casirivimab/imdevimab 2. https://en.m.wikipedia.org/wiki/Casirivimab/imdevimab https://en.m.wikipedia.org/wiki/Casirivimab/imdevimab 3. https://www.covid19treatmentguidelines.nih.gov/immunomodulators/interleukin-6-inhibitors/ https://www.covid19treatmentguidelines.nih.gov/immunomodulat... 4. https://science.sciencemag.org/content/371/6531/850 https://science.sciencemag.org/content/371/6531/850